Pacira BioSciences Inc (PCRX)
25.73
-0.32
(-1.23%)
USD |
NASDAQ |
Apr 30, 10:57
Pacira BioSciences Cash from Operations (Quarterly): 47.58M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 47.58M |
| September 30, 2023 | 44.44M |
| June 30, 2023 | 43.50M |
| March 31, 2023 | 19.13M |
| December 31, 2022 | 42.04M |
| September 30, 2022 | 42.65M |
| June 30, 2022 | 29.81M |
| March 31, 2022 | 30.78M |
| December 31, 2021 | 23.22M |
| September 30, 2021 | 60.29M |
| June 30, 2021 | 30.13M |
| March 31, 2021 | 12.08M |
| December 31, 2020 | 46.67M |
| September 30, 2020 | 39.78M |
| June 30, 2020 | -15.62M |
| March 31, 2020 | 6.208M |
| December 31, 2019 | 25.90M |
| September 30, 2019 | 18.35M |
| June 30, 2019 | 22.76M |
| March 31, 2019 | 3.499M |
| December 31, 2018 | 21.22M |
| September 30, 2018 | 16.63M |
| June 30, 2018 | 13.71M |
| March 31, 2018 | -2.689M |
| December 31, 2017 | 16.93M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.808M |
| June 30, 2017 | 3.656M |
| March 31, 2017 | 0.006M |
| December 31, 2016 | 17.35M |
| September 30, 2016 | 11.68M |
| June 30, 2016 | 7.541M |
| March 31, 2016 | -3.121M |
| December 31, 2015 | 16.99M |
| September 30, 2015 | 4.719M |
| June 30, 2015 | 7.178M |
| March 31, 2015 | -0.87M |
| December 31, 2014 | 14.72M |
| September 30, 2014 | 8.36M |
| June 30, 2014 | 8.218M |
| March 31, 2014 | -4.736M |
| December 31, 2013 | -6.902M |
| September 30, 2013 | -9.837M |
| June 30, 2013 | -13.31M |
| March 31, 2013 | -13.79M |
| December 31, 2012 | -21.18M |
| September 30, 2012 | -11.18M |
| June 30, 2012 | -20.23M |
| March 31, 2012 | -17.54M |
| December 31, 2011 | -7.596M |
| September 30, 2011 | -8.494M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-15.62M
Minimum
Jun 2020
60.29M
Maximum
Sep 2021
29.98M
Average
30.13M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| Dynavax Technologies Corp | 13.77M |
| Arbutus Biopharma Corp | -17.29M |
| Chimerix Inc | -14.59M |
| Karyopharm Therapeutics Inc | -18.58M |
| FibroGen Inc | -18.32M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 8.374M |
| Cash from Financing (Quarterly) | -1.779M |
| Free Cash Flow | 139.49M |
| Free Cash Flow Per Share (Quarterly) | 0.6647 |
| Free Cash Flow to Equity (Quarterly) | 47.93M |
| Free Cash Flow to Firm (Quarterly) | 45.79M |
| Free Cash Flow Yield | 9.90% |